nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A3—Irinotecan—stomach cancer	0.178	0.34	CbGbCtD
Clonidine—ABCB1—Mitomycin—stomach cancer	0.109	0.209	CbGbCtD
Clonidine—CYP3A5—Irinotecan—stomach cancer	0.0431	0.0822	CbGbCtD
Clonidine—CYP3A5—Docetaxel—stomach cancer	0.0316	0.0602	CbGbCtD
Clonidine—CYP1A2—Fluorouracil—stomach cancer	0.0308	0.0587	CbGbCtD
Clonidine—ABCB1—Irinotecan—stomach cancer	0.028	0.0535	CbGbCtD
Clonidine—ABCB1—Docetaxel—stomach cancer	0.0205	0.0392	CbGbCtD
Clonidine—CYP3A4—Irinotecan—stomach cancer	0.0168	0.0321	CbGbCtD
Clonidine—ABCB1—Doxorubicin—stomach cancer	0.0153	0.0292	CbGbCtD
Clonidine—ABCB1—Methotrexate—stomach cancer	0.0148	0.0283	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—stomach cancer	0.0144	0.0275	CbGbCtD
Clonidine—CYP3A4—Docetaxel—stomach cancer	0.0123	0.0235	CbGbCtD
Clonidine—CYP3A4—Doxorubicin—stomach cancer	0.00918	0.0175	CbGbCtD
Clonidine—NISCH—Paclitaxel—Docetaxel—stomach cancer	0.00667	1	CbGdCrCtD
Clonidine—Lofexidine—HTR1A—stomach cancer	0.00408	0.519	CrCbGaD
Clonidine—NISCH—smooth muscle tissue—stomach cancer	0.00199	0.043	CbGeAlD
Clonidine—NISCH—pancreas—stomach cancer	0.00184	0.0398	CbGeAlD
Clonidine—ADRA1D—epithelium—stomach cancer	0.00172	0.0373	CbGeAlD
Clonidine—Diclofenac—ALOX5—stomach cancer	0.00165	0.21	CrCbGaD
Clonidine—NISCH—bone marrow—stomach cancer	0.00145	0.0313	CbGeAlD
Clonidine—Diclofenac—CXCL8—stomach cancer	0.00137	0.174	CrCbGaD
Clonidine—SLC22A3—hematopoietic system—stomach cancer	0.00136	0.0294	CbGeAlD
Clonidine—SLC22A3—smooth muscle tissue—stomach cancer	0.0012	0.0259	CbGeAlD
Clonidine—NISCH—liver—stomach cancer	0.00117	0.0253	CbGeAlD
Clonidine—ADRA1D—endocrine gland—stomach cancer	0.00108	0.0234	CbGeAlD
Clonidine—ADRA1A—hematopoietic system—stomach cancer	0.00108	0.0234	CbGeAlD
Clonidine—SLC22A4—digestive system—stomach cancer	0.00104	0.0225	CbGeAlD
Clonidine—ADRA1A—epithelium—stomach cancer	0.000989	0.0214	CbGeAlD
Clonidine—SLC22A4—bone marrow—stomach cancer	0.000956	0.0207	CbGeAlD
Clonidine—NISCH—lymph node—stomach cancer	0.000896	0.0194	CbGeAlD
Clonidine—CYP1A2—hematopoietic system—stomach cancer	0.000894	0.0194	CbGeAlD
Clonidine—CYP1A1—hematopoietic system—stomach cancer	0.000882	0.0191	CbGeAlD
Clonidine—CYP3A5—hematopoietic system—stomach cancer	0.000863	0.0187	CbGeAlD
Clonidine—ABCB1—blood vessel—stomach cancer	0.000861	0.0186	CbGeAlD
Clonidine—ADRA2C—pancreas—stomach cancer	0.000839	0.0182	CbGeAlD
Clonidine—ADRA2A—hematopoietic system—stomach cancer	0.000822	0.0178	CbGeAlD
Clonidine—SLC22A1—endocrine gland—stomach cancer	0.000816	0.0177	CbGeAlD
Clonidine—CYP1A1—epithelium—stomach cancer	0.000806	0.0175	CbGeAlD
Clonidine—SLC22A3—endocrine gland—stomach cancer	0.00078	0.0169	CbGeAlD
Clonidine—ADRA1A—lymphoid tissue—stomach cancer	0.000761	0.0165	CbGeAlD
Clonidine—SLC22A1—liver—stomach cancer	0.000736	0.0159	CbGeAlD
Clonidine—SLC22A3—liver—stomach cancer	0.000703	0.0152	CbGeAlD
Clonidine—CYP3A5—pancreas—stomach cancer	0.000702	0.0152	CbGeAlD
Clonidine—SLC22A5—digestive system—stomach cancer	0.000687	0.0149	CbGeAlD
Clonidine—ADRA2A—pancreas—stomach cancer	0.00067	0.0145	CbGeAlD
Clonidine—SLC6A2—endocrine gland—stomach cancer	0.000669	0.0145	CbGeAlD
Clonidine—CYP3A4—hematopoietic system—stomach cancer	0.000647	0.014	CbGeAlD
Clonidine—CYP2D6—hematopoietic system—stomach cancer	0.000637	0.0138	CbGeAlD
Clonidine—CYP1A2—digestive system—stomach cancer	0.000622	0.0135	CbGeAlD
Clonidine—ADRA1A—endocrine gland—stomach cancer	0.000622	0.0135	CbGeAlD
Clonidine—CYP1A1—digestive system—stomach cancer	0.000614	0.0133	CbGeAlD
Clonidine—CYP3A5—digestive system—stomach cancer	0.0006	0.013	CbGeAlD
Clonidine—SLC22A4—lymph node—stomach cancer	0.000593	0.0128	CbGeAlD
Clonidine—ADRA1A—liver—stomach cancer	0.00056	0.0121	CbGeAlD
Clonidine—SLC22A3—lymph node—stomach cancer	0.000539	0.0117	CbGeAlD
Clonidine—ADRA2C—liver—stomach cancer	0.000534	0.0116	CbGeAlD
Clonidine—CYP1A2—endocrine gland—stomach cancer	0.000514	0.0111	CbGeAlD
Clonidine—SLC22A5—liver—stomach cancer	0.000511	0.0111	CbGeAlD
Clonidine—CYP1A1—endocrine gland—stomach cancer	0.000507	0.011	CbGeAlD
Clonidine—CYP3A5—endocrine gland—stomach cancer	0.000496	0.0107	CbGeAlD
Clonidine—ADRA2A—endocrine gland—stomach cancer	0.000473	0.0102	CbGeAlD
Clonidine—CYP1A2—liver—stomach cancer	0.000463	0.01	CbGeAlD
Clonidine—SLC6A2—lymph node—stomach cancer	0.000462	0.01	CbGeAlD
Clonidine—ABCB1—hematopoietic system—stomach cancer	0.000458	0.00992	CbGeAlD
Clonidine—CYP1A1—liver—stomach cancer	0.000457	0.00989	CbGeAlD
Clonidine—CYP3A4—digestive system—stomach cancer	0.00045	0.00975	CbGeAlD
Clonidine—CYP3A5—liver—stomach cancer	0.000447	0.00967	CbGeAlD
Clonidine—CYP2D6—digestive system—stomach cancer	0.000443	0.00959	CbGeAlD
Clonidine—ABCB1—epithelium—stomach cancer	0.000419	0.00907	CbGeAlD
Clonidine—ADRA2C—lymph node—stomach cancer	0.000409	0.00886	CbGeAlD
Clonidine—Diclofenac—PTGS2—stomach cancer	0.0004	0.0508	CrCbGaD
Clonidine—SLC22A5—lymph node—stomach cancer	0.000392	0.00849	CbGeAlD
Clonidine—ABCB1—pancreas—stomach cancer	0.000373	0.00808	CbGeAlD
Clonidine—CYP3A4—endocrine gland—stomach cancer	0.000372	0.00805	CbGeAlD
Clonidine—CYP2D6—endocrine gland—stomach cancer	0.000366	0.00792	CbGeAlD
Clonidine—Diclofenac—ALB—stomach cancer	0.000356	0.0453	CrCbGaD
Clonidine—CYP1A1—lymph node—stomach cancer	0.00035	0.00759	CbGeAlD
Clonidine—CYP3A4—liver—stomach cancer	0.000335	0.00726	CbGeAlD
Clonidine—CYP2D6—liver—stomach cancer	0.00033	0.00714	CbGeAlD
Clonidine—ADRA2A—lymph node—stomach cancer	0.000327	0.00707	CbGeAlD
Clonidine—ABCB1—lymphoid tissue—stomach cancer	0.000323	0.00698	CbGeAlD
Clonidine—ABCB1—digestive system—stomach cancer	0.000319	0.0069	CbGeAlD
Clonidine—ABCB1—bone marrow—stomach cancer	0.000294	0.00636	CbGeAlD
Clonidine—ABCB1—endocrine gland—stomach cancer	0.000263	0.0057	CbGeAlD
Clonidine—Rhinitis—Epirubicin—stomach cancer	0.000254	0.000953	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—stomach cancer	0.000254	0.000952	CcSEcCtD
Clonidine—Nervous system disorder—Capecitabine—stomach cancer	0.000254	0.00095	CcSEcCtD
Clonidine—Hepatitis—Epirubicin—stomach cancer	0.000254	0.00095	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—stomach cancer	0.000253	0.000949	CcSEcCtD
Clonidine—Diarrhoea—Fluorouracil—stomach cancer	0.000253	0.000949	CcSEcCtD
Clonidine—Thrombocytopenia—Capecitabine—stomach cancer	0.000253	0.000949	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—stomach cancer	0.000253	0.000947	CcSEcCtD
Clonidine—Tachycardia—Capecitabine—stomach cancer	0.000252	0.000946	CcSEcCtD
Clonidine—Hypoaesthesia—Epirubicin—stomach cancer	0.000252	0.000945	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—stomach cancer	0.000251	0.000942	CcSEcCtD
Clonidine—Skin disorder—Capecitabine—stomach cancer	0.000251	0.000941	CcSEcCtD
Clonidine—Sweating—Doxorubicin—stomach cancer	0.000251	0.000939	CcSEcCtD
Clonidine—Hyperhidrosis—Capecitabine—stomach cancer	0.00025	0.000937	CcSEcCtD
Clonidine—Hypotension—Docetaxel—stomach cancer	0.00025	0.000935	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—stomach cancer	0.000246	0.000924	CcSEcCtD
Clonidine—Anorexia—Capecitabine—stomach cancer	0.000246	0.000924	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—stomach cancer	0.000246	0.000921	CcSEcCtD
Clonidine—Vomiting—Irinotecan—stomach cancer	0.000246	0.00092	CcSEcCtD
Clonidine—Dizziness—Fluorouracil—stomach cancer	0.000245	0.000917	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—stomach cancer	0.000244	0.000915	CcSEcCtD
Clonidine—Rash—Irinotecan—stomach cancer	0.000244	0.000913	CcSEcCtD
Clonidine—Dermatitis—Irinotecan—stomach cancer	0.000243	0.000912	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000243	0.000912	CcSEcCtD
Clonidine—Headache—Irinotecan—stomach cancer	0.000242	0.000907	CcSEcCtD
Clonidine—Hypotension—Capecitabine—stomach cancer	0.000242	0.000905	CcSEcCtD
Clonidine—Insomnia—Docetaxel—stomach cancer	0.000242	0.000905	CcSEcCtD
Clonidine—Paraesthesia—Docetaxel—stomach cancer	0.00024	0.000899	CcSEcCtD
Clonidine—Alopecia—Methotrexate—stomach cancer	0.000239	0.000897	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—stomach cancer	0.000239	0.000895	CcSEcCtD
Clonidine—Dyspnoea—Docetaxel—stomach cancer	0.000238	0.000892	CcSEcCtD
Clonidine—ABCB1—liver—stomach cancer	0.000237	0.00514	CbGeAlD
Clonidine—Somnolence—Docetaxel—stomach cancer	0.000237	0.00089	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—stomach cancer	0.000237	0.000889	CcSEcCtD
Clonidine—Eye disorder—Epirubicin—stomach cancer	0.000237	0.000888	CcSEcCtD
Clonidine—Tinnitus—Epirubicin—stomach cancer	0.000236	0.000886	CcSEcCtD
Clonidine—Erythema—Methotrexate—stomach cancer	0.000236	0.000884	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000236	0.000883	CcSEcCtD
Clonidine—Cardiac disorder—Epirubicin—stomach cancer	0.000235	0.000882	CcSEcCtD
Clonidine—Vomiting—Fluorouracil—stomach cancer	0.000235	0.000882	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—stomach cancer	0.000235	0.000881	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—stomach cancer	0.000235	0.000879	CcSEcCtD
Clonidine—Insomnia—Capecitabine—stomach cancer	0.000234	0.000876	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000233	0.000875	CcSEcCtD
Clonidine—Rash—Fluorouracil—stomach cancer	0.000233	0.000874	CcSEcCtD
Clonidine—Dermatitis—Fluorouracil—stomach cancer	0.000233	0.000873	CcSEcCtD
Clonidine—Paraesthesia—Capecitabine—stomach cancer	0.000232	0.00087	CcSEcCtD
Clonidine—Decreased appetite—Docetaxel—stomach cancer	0.000232	0.00087	CcSEcCtD
Clonidine—Headache—Fluorouracil—stomach cancer	0.000232	0.000869	CcSEcCtD
Clonidine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000231	0.000864	CcSEcCtD
Clonidine—Dyspnoea—Capecitabine—stomach cancer	0.00023	0.000864	CcSEcCtD
Clonidine—Fatigue—Docetaxel—stomach cancer	0.00023	0.000863	CcSEcCtD
Clonidine—Angiopathy—Epirubicin—stomach cancer	0.00023	0.000862	CcSEcCtD
Clonidine—Nausea—Irinotecan—stomach cancer	0.000229	0.00086	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—stomach cancer	0.000228	0.000856	CcSEcCtD
Clonidine—Pain—Docetaxel—stomach cancer	0.000228	0.000856	CcSEcCtD
Clonidine—Constipation—Docetaxel—stomach cancer	0.000228	0.000856	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—stomach cancer	0.000226	0.000849	CcSEcCtD
Clonidine—Decreased appetite—Capecitabine—stomach cancer	0.000225	0.000842	CcSEcCtD
Clonidine—Alopecia—Epirubicin—stomach cancer	0.000224	0.00084	CcSEcCtD
Clonidine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000223	0.000837	CcSEcCtD
Clonidine—Fatigue—Capecitabine—stomach cancer	0.000223	0.000835	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—stomach cancer	0.000222	0.000833	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—stomach cancer	0.000222	0.000832	CcSEcCtD
Clonidine—Pain—Capecitabine—stomach cancer	0.000221	0.000829	CcSEcCtD
Clonidine—Constipation—Capecitabine—stomach cancer	0.000221	0.000829	CcSEcCtD
Clonidine—Erythema—Epirubicin—stomach cancer	0.000221	0.000827	CcSEcCtD
Clonidine—Feeling abnormal—Docetaxel—stomach cancer	0.00022	0.000825	CcSEcCtD
Clonidine—Nausea—Fluorouracil—stomach cancer	0.00022	0.000824	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—stomach cancer	0.000219	0.000822	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—stomach cancer	0.000219	0.00082	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—stomach cancer	0.000219	0.00082	CcSEcCtD
Clonidine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000218	0.000818	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—stomach cancer	0.000218	0.000816	CcSEcCtD
Clonidine—Tension—Epirubicin—stomach cancer	0.000217	0.000812	CcSEcCtD
Clonidine—Nervousness—Epirubicin—stomach cancer	0.000214	0.000803	CcSEcCtD
Clonidine—Feeling abnormal—Capecitabine—stomach cancer	0.000213	0.000798	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—stomach cancer	0.000213	0.000798	CcSEcCtD
Clonidine—Malaise—Methotrexate—stomach cancer	0.000213	0.000797	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—stomach cancer	0.000212	0.000795	CcSEcCtD
Clonidine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000211	0.000792	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000211	0.000792	CcSEcCtD
Clonidine—Abdominal pain—Docetaxel—stomach cancer	0.000211	0.000791	CcSEcCtD
Clonidine—Body temperature increased—Docetaxel—stomach cancer	0.000211	0.000791	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—stomach cancer	0.00021	0.000785	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—stomach cancer	0.000208	0.000779	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—stomach cancer	0.000207	0.000777	CcSEcCtD
Clonidine—Cough—Methotrexate—stomach cancer	0.000206	0.000771	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—stomach cancer	0.000206	0.00077	CcSEcCtD
Clonidine—Urticaria—Capecitabine—stomach cancer	0.000205	0.00077	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—stomach cancer	0.000205	0.000767	CcSEcCtD
Clonidine—Body temperature increased—Capecitabine—stomach cancer	0.000204	0.000766	CcSEcCtD
Clonidine—Abdominal pain—Capecitabine—stomach cancer	0.000204	0.000766	CcSEcCtD
Clonidine—Erythema—Doxorubicin—stomach cancer	0.000204	0.000765	CcSEcCtD
Clonidine—Agitation—Epirubicin—stomach cancer	0.000203	0.00076	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—stomach cancer	0.000201	0.000752	CcSEcCtD
Clonidine—Chest pain—Methotrexate—stomach cancer	0.000201	0.000752	CcSEcCtD
Clonidine—Tension—Doxorubicin—stomach cancer	0.0002	0.000751	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000199	0.000747	CcSEcCtD
Clonidine—Malaise—Epirubicin—stomach cancer	0.000199	0.000746	CcSEcCtD
Clonidine—Discomfort—Methotrexate—stomach cancer	0.000198	0.000743	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—stomach cancer	0.000198	0.000743	CcSEcCtD
Clonidine—Syncope—Epirubicin—stomach cancer	0.000198	0.000742	CcSEcCtD
Clonidine—Hypersensitivity—Docetaxel—stomach cancer	0.000197	0.000737	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—stomach cancer	0.000196	0.000736	CcSEcCtD
Clonidine—Palpitations—Epirubicin—stomach cancer	0.000195	0.000731	CcSEcCtD
Clonidine—Confusional state—Methotrexate—stomach cancer	0.000194	0.000727	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—stomach cancer	0.000194	0.000727	CcSEcCtD
Clonidine—Cough—Epirubicin—stomach cancer	0.000193	0.000722	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—stomach cancer	0.000192	0.000721	CcSEcCtD
Clonidine—Asthenia—Docetaxel—stomach cancer	0.000192	0.000718	CcSEcCtD
Clonidine—Infection—Methotrexate—stomach cancer	0.000191	0.000717	CcSEcCtD
Clonidine—Hypersensitivity—Capecitabine—stomach cancer	0.00019	0.000714	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000189	0.00071	CcSEcCtD
Clonidine—Pruritus—Docetaxel—stomach cancer	0.000189	0.000708	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—stomach cancer	0.000189	0.000707	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—stomach cancer	0.000188	0.000706	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—stomach cancer	0.000188	0.000704	CcSEcCtD
Clonidine—Chest pain—Epirubicin—stomach cancer	0.000188	0.000704	CcSEcCtD
Clonidine—Agitation—Doxorubicin—stomach cancer	0.000188	0.000703	CcSEcCtD
Clonidine—Anxiety—Epirubicin—stomach cancer	0.000187	0.000702	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—stomach cancer	0.000187	0.000701	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000187	0.000699	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—stomach cancer	0.000186	0.000697	CcSEcCtD
Clonidine—Discomfort—Epirubicin—stomach cancer	0.000186	0.000696	CcSEcCtD
Clonidine—Asthenia—Capecitabine—stomach cancer	0.000185	0.000695	CcSEcCtD
Clonidine—Malaise—Doxorubicin—stomach cancer	0.000184	0.00069	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—stomach cancer	0.000184	0.000689	CcSEcCtD
Clonidine—Anorexia—Methotrexate—stomach cancer	0.000183	0.000688	CcSEcCtD
Clonidine—Syncope—Doxorubicin—stomach cancer	0.000183	0.000686	CcSEcCtD
Clonidine—Pruritus—Capecitabine—stomach cancer	0.000183	0.000686	CcSEcCtD
Clonidine—Diarrhoea—Docetaxel—stomach cancer	0.000183	0.000685	CcSEcCtD
Clonidine—ABCB1—lymph node—stomach cancer	0.000182	0.00394	CbGeAlD
Clonidine—Confusional state—Epirubicin—stomach cancer	0.000182	0.000681	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—stomach cancer	0.00018	0.000676	CcSEcCtD
Clonidine—Oedema—Epirubicin—stomach cancer	0.00018	0.000675	CcSEcCtD
Clonidine—Hypotension—Methotrexate—stomach cancer	0.00018	0.000674	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—stomach cancer	0.000179	0.000673	CcSEcCtD
Clonidine—Infection—Epirubicin—stomach cancer	0.000179	0.000671	CcSEcCtD
Clonidine—Cough—Doxorubicin—stomach cancer	0.000178	0.000668	CcSEcCtD
Clonidine—Shock—Epirubicin—stomach cancer	0.000177	0.000664	CcSEcCtD
Clonidine—Diarrhoea—Capecitabine—stomach cancer	0.000177	0.000663	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—stomach cancer	0.000177	0.000662	CcSEcCtD
Clonidine—Dizziness—Docetaxel—stomach cancer	0.000177	0.000662	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—stomach cancer	0.000176	0.000661	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—stomach cancer	0.000176	0.000659	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000175	0.000657	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—stomach cancer	0.000175	0.000656	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—stomach cancer	0.000174	0.000653	CcSEcCtD
Clonidine—Insomnia—Methotrexate—stomach cancer	0.000174	0.000652	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—stomach cancer	0.000174	0.000652	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—stomach cancer	0.000174	0.000652	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—stomach cancer	0.000173	0.000649	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—stomach cancer	0.000173	0.000648	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000173	0.000647	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—stomach cancer	0.000172	0.000644	CcSEcCtD
Clonidine—Anorexia—Epirubicin—stomach cancer	0.000172	0.000643	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—stomach cancer	0.000172	0.000643	CcSEcCtD
Clonidine—Somnolence—Methotrexate—stomach cancer	0.000171	0.000641	CcSEcCtD
Clonidine—Dizziness—Capecitabine—stomach cancer	0.000171	0.000641	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—stomach cancer	0.00017	0.000637	CcSEcCtD
Clonidine—Vomiting—Docetaxel—stomach cancer	0.00017	0.000636	CcSEcCtD
Clonidine—Rash—Docetaxel—stomach cancer	0.000168	0.000631	CcSEcCtD
Clonidine—Hypotension—Epirubicin—stomach cancer	0.000168	0.000631	CcSEcCtD
Clonidine—Dermatitis—Docetaxel—stomach cancer	0.000168	0.00063	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—stomach cancer	0.000168	0.00063	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—stomach cancer	0.000167	0.000627	CcSEcCtD
Clonidine—Headache—Docetaxel—stomach cancer	0.000167	0.000627	CcSEcCtD
Clonidine—Oedema—Doxorubicin—stomach cancer	0.000167	0.000625	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000166	0.000623	CcSEcCtD
Clonidine—Fatigue—Methotrexate—stomach cancer	0.000166	0.000622	CcSEcCtD
Clonidine—Infection—Doxorubicin—stomach cancer	0.000166	0.00062	CcSEcCtD
Clonidine—Pain—Methotrexate—stomach cancer	0.000165	0.000617	CcSEcCtD
Clonidine—Vomiting—Capecitabine—stomach cancer	0.000164	0.000616	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000164	0.000615	CcSEcCtD
Clonidine—Shock—Doxorubicin—stomach cancer	0.000164	0.000614	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—stomach cancer	0.000163	0.000613	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000163	0.000612	CcSEcCtD
Clonidine—Rash—Capecitabine—stomach cancer	0.000163	0.000611	CcSEcCtD
Clonidine—Insomnia—Epirubicin—stomach cancer	0.000163	0.000611	CcSEcCtD
Clonidine—Dermatitis—Capecitabine—stomach cancer	0.000163	0.00061	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—stomach cancer	0.000163	0.00061	CcSEcCtD
Clonidine—Headache—Capecitabine—stomach cancer	0.000162	0.000607	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—stomach cancer	0.000162	0.000607	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—stomach cancer	0.000162	0.000606	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000161	0.000604	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—stomach cancer	0.000161	0.000602	CcSEcCtD
Clonidine—Somnolence—Epirubicin—stomach cancer	0.00016	0.0006	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—stomach cancer	0.000159	0.000595	CcSEcCtD
Clonidine—Nausea—Docetaxel—stomach cancer	0.000159	0.000594	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—stomach cancer	0.000159	0.000594	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000157	0.00059	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—stomach cancer	0.000157	0.000587	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—stomach cancer	0.000156	0.000584	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000155	0.000583	CcSEcCtD
Clonidine—Fatigue—Epirubicin—stomach cancer	0.000155	0.000582	CcSEcCtD
Clonidine—Pain—Epirubicin—stomach cancer	0.000154	0.000577	CcSEcCtD
Clonidine—Constipation—Epirubicin—stomach cancer	0.000154	0.000577	CcSEcCtD
Clonidine—Nausea—Capecitabine—stomach cancer	0.000154	0.000576	CcSEcCtD
Clonidine—Urticaria—Methotrexate—stomach cancer	0.000153	0.000573	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—stomach cancer	0.000152	0.00057	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—stomach cancer	0.000152	0.00057	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000152	0.000569	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—stomach cancer	0.000151	0.000565	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—stomach cancer	0.00015	0.000561	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—stomach cancer	0.000149	0.000557	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—stomach cancer	0.000148	0.000556	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—stomach cancer	0.000148	0.000555	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000147	0.000552	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—stomach cancer	0.000145	0.000543	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000144	0.000539	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—stomach cancer	0.000144	0.000538	CcSEcCtD
Clonidine—Urticaria—Epirubicin—stomach cancer	0.000143	0.000536	CcSEcCtD
Clonidine—Pain—Doxorubicin—stomach cancer	0.000143	0.000534	CcSEcCtD
Clonidine—Constipation—Doxorubicin—stomach cancer	0.000143	0.000534	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—stomach cancer	0.000142	0.000534	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—stomach cancer	0.000142	0.000534	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—stomach cancer	0.000142	0.000531	CcSEcCtD
Clonidine—Asthenia—Methotrexate—stomach cancer	0.000138	0.000518	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—stomach cancer	0.000137	0.000515	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000136	0.000511	CcSEcCtD
Clonidine—Pruritus—Methotrexate—stomach cancer	0.000136	0.00051	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—stomach cancer	0.000133	0.000497	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—stomach cancer	0.000132	0.000496	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—stomach cancer	0.000132	0.000494	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—stomach cancer	0.000132	0.000494	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—stomach cancer	0.000132	0.000494	CcSEcCtD
Clonidine—Asthenia—Epirubicin—stomach cancer	0.000129	0.000484	CcSEcCtD
Clonidine—Pruritus—Epirubicin—stomach cancer	0.000127	0.000478	CcSEcCtD
Clonidine—Dizziness—Methotrexate—stomach cancer	0.000127	0.000477	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—stomach cancer	0.000123	0.000462	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—stomach cancer	0.000123	0.00046	CcSEcCtD
Clonidine—Vomiting—Methotrexate—stomach cancer	0.000122	0.000459	CcSEcCtD
Clonidine—Rash—Methotrexate—stomach cancer	0.000121	0.000455	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—stomach cancer	0.000121	0.000454	CcSEcCtD
Clonidine—Headache—Methotrexate—stomach cancer	0.000121	0.000452	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—stomach cancer	0.00012	0.000448	CcSEcCtD
Clonidine—Dizziness—Epirubicin—stomach cancer	0.000119	0.000446	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—stomach cancer	0.000118	0.000442	CcSEcCtD
Clonidine—Vomiting—Epirubicin—stomach cancer	0.000115	0.000429	CcSEcCtD
Clonidine—Nausea—Methotrexate—stomach cancer	0.000114	0.000428	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—stomach cancer	0.000114	0.000427	CcSEcCtD
Clonidine—Rash—Epirubicin—stomach cancer	0.000114	0.000426	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—stomach cancer	0.000113	0.000425	CcSEcCtD
Clonidine—Headache—Epirubicin—stomach cancer	0.000113	0.000423	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—stomach cancer	0.00011	0.000413	CcSEcCtD
Clonidine—Nausea—Epirubicin—stomach cancer	0.000107	0.000401	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—stomach cancer	0.000106	0.000397	CcSEcCtD
Clonidine—Rash—Doxorubicin—stomach cancer	0.000105	0.000394	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—stomach cancer	0.000105	0.000393	CcSEcCtD
Clonidine—Headache—Doxorubicin—stomach cancer	0.000104	0.000391	CcSEcCtD
Clonidine—Nausea—Doxorubicin—stomach cancer	9.9e-05	0.000371	CcSEcCtD
Clonidine—ABCB1—Metabolism—TYMS—stomach cancer	8.88e-06	5.98e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—HMOX1—stomach cancer	8.88e-06	5.98e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.87e-06	5.98e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6R—stomach cancer	8.87e-06	5.98e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	8.86e-06	5.97e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—MAPK1—stomach cancer	8.84e-06	5.96e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—EGFR—stomach cancer	8.84e-06	5.96e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	8.83e-06	5.95e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—stomach cancer	8.81e-06	5.94e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GSTM1—stomach cancer	8.78e-06	5.92e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—RHOA—stomach cancer	8.71e-06	5.87e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	8.7e-06	5.86e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	8.7e-06	5.86e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	8.65e-06	5.83e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	8.63e-06	5.82e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NOS3—stomach cancer	8.62e-06	5.81e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.56e-06	5.77e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTT1—stomach cancer	8.49e-06	5.72e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—APC—stomach cancer	8.48e-06	5.72e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	8.47e-06	5.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—PIK3CA—stomach cancer	8.45e-06	5.69e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—stomach cancer	8.44e-06	5.69e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SERPINE1—stomach cancer	8.44e-06	5.69e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	8.42e-06	5.67e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP2A6—stomach cancer	8.39e-06	5.66e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—TYMS—stomach cancer	8.37e-06	5.64e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—KRAS—stomach cancer	8.35e-06	5.63e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PPARG—stomach cancer	8.34e-06	5.62e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	8.32e-06	5.6e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	8.3e-06	5.6e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	8.27e-06	5.58e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GSTM1—stomach cancer	8.27e-06	5.57e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ERCC2—stomach cancer	8.25e-06	5.56e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	8.24e-06	5.55e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	8.22e-06	5.54e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	8.21e-06	5.54e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	8.2e-06	5.53e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ALB—stomach cancer	8.18e-06	5.51e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKR1C3—stomach cancer	8.16e-06	5.5e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—RHOA—stomach cancer	8.14e-06	5.49e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	8.12e-06	5.48e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	8.07e-06	5.44e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL6—stomach cancer	8.06e-06	5.43e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NOS3—stomach cancer	8.05e-06	5.43e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—RHOA—stomach cancer	8.01e-06	5.4e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ENO1—stomach cancer	7.96e-06	5.36e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NOS3—stomach cancer	7.93e-06	5.34e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCND1—stomach cancer	7.89e-06	5.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APC—stomach cancer	7.88e-06	5.31e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6R—stomach cancer	7.88e-06	5.31e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—JUN—stomach cancer	7.88e-06	5.31e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARG—stomach cancer	7.88e-06	5.31e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—NOS3—stomach cancer	7.82e-06	5.27e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ERCC2—stomach cancer	7.78e-06	5.24e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	7.77e-06	5.24e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—MTHFR—stomach cancer	7.76e-06	5.23e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	7.73e-06	5.21e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	7.73e-06	5.21e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	7.67e-06	5.17e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—stomach cancer	7.66e-06	5.16e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	7.65e-06	5.16e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	7.64e-06	5.15e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTP1—stomach cancer	7.62e-06	5.14e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	7.6e-06	5.12e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	7.55e-06	5.09e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	7.55e-06	5.09e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	7.53e-06	5.08e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HMOX1—stomach cancer	7.52e-06	5.07e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ALB—stomach cancer	7.5e-06	5.05e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	7.47e-06	5.03e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	7.45e-06	5.02e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	7.41e-06	5e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	7.39e-06	4.98e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	7.38e-06	4.97e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	7.32e-06	4.93e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—MTHFR—stomach cancer	7.31e-06	4.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	7.3e-06	4.92e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	7.27e-06	4.9e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	7.18e-06	4.84e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	7.18e-06	4.84e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—NOS3—stomach cancer	7.17e-06	4.83e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—stomach cancer	7.16e-06	4.82e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CAV1—stomach cancer	7.16e-06	4.82e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	7.14e-06	4.82e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOA1—stomach cancer	7.14e-06	4.81e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	7.13e-06	4.8e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RHOA—stomach cancer	7.11e-06	4.8e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—JUN—stomach cancer	7.11e-06	4.79e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	7.1e-06	4.78e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TYMS—stomach cancer	7.09e-06	4.78e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ALB—stomach cancer	7.08e-06	4.77e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CD44—stomach cancer	7.06e-06	4.76e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOS3—stomach cancer	7.04e-06	4.75e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	7.03e-06	4.74e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTM1—stomach cancer	7.01e-06	4.72e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	6.99e-06	4.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	6.98e-06	4.7e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	6.92e-06	4.66e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	6.89e-06	4.65e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	6.88e-06	4.64e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	6.87e-06	4.63e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	6.86e-06	4.63e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	6.85e-06	4.62e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—stomach cancer	6.81e-06	4.59e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—stomach cancer	6.79e-06	4.58e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	6.78e-06	4.57e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NOS3—stomach cancer	6.77e-06	4.57e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CAV1—stomach cancer	6.74e-06	4.54e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	6.73e-06	4.53e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOA1—stomach cancer	6.73e-06	4.53e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	6.71e-06	4.52e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—stomach cancer	6.69e-06	4.51e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—stomach cancer	6.66e-06	4.49e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—JUN—stomach cancer	6.64e-06	4.48e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	6.61e-06	4.46e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ERCC2—stomach cancer	6.59e-06	4.44e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	6.59e-06	4.44e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—stomach cancer	6.56e-06	4.42e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—stomach cancer	6.55e-06	4.42e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	6.54e-06	4.41e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—JUN—stomach cancer	6.54e-06	4.41e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	6.51e-06	4.39e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—stomach cancer	6.46e-06	4.36e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	6.44e-06	4.34e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—stomach cancer	6.36e-06	4.29e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	6.34e-06	4.27e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—stomach cancer	6.33e-06	4.27e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—stomach cancer	6.29e-06	4.24e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	6.28e-06	4.24e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	6.25e-06	4.21e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	6.23e-06	4.2e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	6.21e-06	4.19e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	6.21e-06	4.18e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—stomach cancer	6.2e-06	4.18e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	6.19e-06	4.17e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MTHFR—stomach cancer	6.19e-06	4.17e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—stomach cancer	6.19e-06	4.17e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	6.19e-06	4.17e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	6.15e-06	4.15e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	6.12e-06	4.12e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	6.1e-06	4.11e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	6e-06	4.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	5.94e-06	4e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—stomach cancer	5.93e-06	4e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTP1—stomach cancer	5.88e-06	3.97e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	5.88e-06	3.96e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—stomach cancer	5.85e-06	3.94e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	5.82e-06	3.92e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—JUN—stomach cancer	5.81e-06	3.91e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HMOX1—stomach cancer	5.8e-06	3.91e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	5.8e-06	3.91e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	5.8e-06	3.91e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	5.77e-06	3.89e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—stomach cancer	5.75e-06	3.87e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—stomach cancer	5.72e-06	3.85e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CAV1—stomach cancer	5.71e-06	3.85e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	5.71e-06	3.85e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOA1—stomach cancer	5.7e-06	3.84e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	5.67e-06	3.82e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALB—stomach cancer	5.66e-06	3.81e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	5.65e-06	3.81e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	5.65e-06	3.81e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	5.63e-06	3.79e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	5.59e-06	3.77e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	5.59e-06	3.77e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	5.52e-06	3.72e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	5.49e-06	3.7e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	5.49e-06	3.7e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TYMS—stomach cancer	5.47e-06	3.69e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.46e-06	3.68e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—stomach cancer	5.42e-06	3.65e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NOS3—stomach cancer	5.41e-06	3.65e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTM1—stomach cancer	5.41e-06	3.64e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	5.41e-06	3.64e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	5.4e-06	3.64e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—JUN—stomach cancer	5.4e-06	3.64e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	5.37e-06	3.62e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—stomach cancer	5.34e-06	3.6e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALB—stomach cancer	5.33e-06	3.59e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	5.28e-06	3.56e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—stomach cancer	5.25e-06	3.54e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	5.25e-06	3.54e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	5.23e-06	3.53e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	5.22e-06	3.52e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—stomach cancer	5.22e-06	3.52e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—stomach cancer	5.2e-06	3.5e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—stomach cancer	5.19e-06	3.5e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	5.14e-06	3.46e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	5.14e-06	3.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	5.1e-06	3.44e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NOS3—stomach cancer	5.1e-06	3.44e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ERCC2—stomach cancer	5.08e-06	3.43e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	5.07e-06	3.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	5.02e-06	3.39e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—stomach cancer	5.02e-06	3.38e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—stomach cancer	4.97e-06	3.35e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—stomach cancer	4.95e-06	3.34e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—stomach cancer	4.93e-06	3.32e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	4.86e-06	3.27e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	4.85e-06	3.27e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	4.8e-06	3.23e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MTHFR—stomach cancer	4.78e-06	3.22e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—stomach cancer	4.76e-06	3.21e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	4.71e-06	3.18e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—stomach cancer	4.69e-06	3.16e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—stomach cancer	4.67e-06	3.15e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	4.67e-06	3.15e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—stomach cancer	4.66e-06	3.14e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	4.57e-06	3.08e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	4.57e-06	3.08e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	4.53e-06	3.05e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALB—stomach cancer	4.52e-06	3.04e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	4.49e-06	3.03e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	4.46e-06	3.01e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	4.46e-06	3.01e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAV1—stomach cancer	4.41e-06	2.97e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—stomach cancer	4.4e-06	2.97e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOA1—stomach cancer	4.4e-06	2.96e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—stomach cancer	4.38e-06	2.96e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—stomach cancer	4.34e-06	2.92e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NOS3—stomach cancer	4.32e-06	2.91e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—stomach cancer	4.32e-06	2.91e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	4.31e-06	2.91e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—stomach cancer	4.3e-06	2.9e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	4.24e-06	2.86e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	4.24e-06	2.86e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—stomach cancer	4.19e-06	2.83e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	4.13e-06	2.78e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—stomach cancer	4.03e-06	2.72e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—stomach cancer	4.01e-06	2.7e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	4.01e-06	2.7e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	3.96e-06	2.67e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—stomach cancer	3.95e-06	2.66e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—stomach cancer	3.95e-06	2.66e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—stomach cancer	3.88e-06	2.61e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—stomach cancer	3.83e-06	2.58e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—stomach cancer	3.81e-06	2.57e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	3.68e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	3.67e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—stomach cancer	3.56e-06	2.4e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—stomach cancer	3.51e-06	2.36e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALB—stomach cancer	3.48e-06	2.35e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	3.41e-06	2.3e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NOS3—stomach cancer	3.33e-06	2.25e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—stomach cancer	3.26e-06	2.2e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—stomach cancer	3.05e-06	2.05e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—stomach cancer	3.04e-06	2.05e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.87e-06	1.93e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.43e-06	1.64e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.88e-06	1.26e-05	CbGpPWpGaD
